A COMPARATIVE STUDY OF DEXMEDETOMIDINE AND CLONIDINE AS AN ADJUVANT TO ROPIVACAINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK

Authors

  • NAGALINGAM NATARAJAN Department of Anaesthesiology, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India.
  • GOPALAKRISHNAN KUPPUSAMY Department of Anaesthesiology, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India.
  • AISHWARYA RAMANATHAN Department of Anaesthesiology, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India.
  • SMITUL DAVE Department of Anaesthesiology, Sri Lakshmi Narayana Institute of Medical Sciences, Pondicherry, India.

DOI:

https://doi.org/10.22159/ajpcr.2022.v15i2.43752

Keywords:

Supraclavicular brachial plexus block, Dexmedetomidine, Clonidine, Ropivacaine, postoperative analgesia

Abstract

Objectives: Ultrasound-guided supraclavicular brachial plexus block is the most commonly performed approach for the upper limb surgeries and perioperative pain relief. This study was conducted to compare the post-operative analgesic efficacy of dexmedetomidine and clonidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block in patients undergoing upper limb surgeries.

Methods: This was a prospective, randomized, and double-blinded comparative research that included 60 ASA PS I and II patients who were scheduled for the upper limb surgery. The patients were randomized into two groups, namely, Group C and Group D, with 30 patients each. The patients in Group D were given USG-guided supraclavicular brachial plexus block with 30 ml of 0.5% ropivacaine and dexmedetomidine 1 μg/kg and patients in Group C received 30 ml of 0.5% ropivacaine and clonidine 1 μg/kg. The patients were monitored for post-operative and interpreted by visual analog score and duration of analgesia. The Student’s independent t-test was employed for comparing continuous variables. Chi-square test or Fisher’s exact test, whichever is appropriate, was applied for comparing categorical variables.

Results: The mean duration of analgesia was longer and the mean consumption of rescue analgesics was lower in Group D as compared to Group C. No significant post-operative complications or local side effects related to the block were noted.

Conclusion: Dexmedetomidine prolongs the duration of sensory and motor block as well as the duration of post-operative analgesia as compared to clonidine when used as an adjuvant to ropivacaine in supraclavicular brachial plexus block.

Downloads

Download data is not yet available.

References

Satapathy AR, Coventry DM. Axillary brachial plexus block. Anesthesiol Res Pract 2011;2011:173796.

Mian A, Chaudhry I, Huang R, Rizk E, Tubbs RS, Loukas M. Brachial plexus anesthesia: A review of the relevant anatomy, complications, and anatomical variations. Clin Anat 2014;27:210-21.

Kulenkampff D. Brachial Plexus Anaesthesia. Ann Surg 1928;87:883-91.

Abdallah FW, Brull R. Facilitatory effects of perineural dexmedetomidine on neuraxial and peripheral nerve block: A systematic review and meta-analysis. Br J Anaesth 2013;110:915-25.

Kaur M, Singh PM. Current role of dexmedetomidine in clinical anesthesia and intensive care. Anesth Essays Res 2011;5:128-33.

Agarwal S, Aggarwal R, Gupta P. Dexmedetomidine prolongs the effect of bupivacaine in supraclavicular brachial plexus block. J Anaesthesiol Clin Pharmacol 2014;30:36-40.

Ali QE, Manjunatha L, Amir SH, Jamil S, Quadir A. Efficacy of clonidine as an adjuvant to ropivacaine in supraclavicular brachial plexus block: A prospective study. Indian J Anaesth 2014;58:709-13.

Sessler CN, Grap MJ, Ramsay MA. Evaluating and monitoring analgesia and sedation in the intensive care unit. Crit Care Lond Engl 2008;12 Suppl 3:S2.

Swami SS, Keniya VM, Ladi SD, Rao R. Comparison of dexmedetomidine and clonidine (α2 agonist drugs) as an adjuvant to local anaesthesia in supraclavicular brachial plexus block: A randomised double-blind prospective study. Indian J Anaesth 2012;56:243-9.

Kanazi GE, Aouad MT, Jabbour-Khoury SI, Al Jazzar MD, Alameddine MM, Al-Yaman R, et al. Effect of low-dose dexmedetomidine or clonidine on the characteristics of bupivacaine spinal block. Acta Anaesthesiol Scand 2006;50:222-7.

Simpson D, Curran MP, Oldfield V, Keating GM. Ropivacaine: A review of its use in regional anaesthesia and acute pain management. Drugs 2005;65:2675-717.

Klein SM, Greengrass RA, Steele SM, D’Ercole FJ, Speer KP, Gleason DH, et al. A comparison of 0.5% bupivacaine, 0.5% ropivacaine, and 0.75% ropivacaine for interscalene brachial plexus block. Anesth Analg 1998;87:1316-9.

Hickey R, Rowley CL, Candido KD, Hoffman J, Ramamurthy S, Winnie AP. A comparative study of 0.25% ropivacaine and 0.25% bupivacaine for brachial plexus block. Anesth Analg 1992;75:602-6.

Harshavardhana HS. Efficacy of dexmedetomidine compared to clonidine added to ropivacaine in supraclavicular nerve blocks: A prospective, randomized, double blind study. Int J Med Health Sci 2014;3:127-32.

Kanvee V, Patel K, Doshi M, Mayur V, Kapil G. Comparative study of clonidine and dexmedetomidine as an adjuvant with ropivacaine in supraclavicular brachial plexus block for upper limb surgery. J Res Med Dent Sci 2015;3:127.

Bafna U, Yadav N, Khandelwal M, Mistry T, Chatterjee CS, Sharma R. Comparison of 0.5% ropivacaine alone and in combination with clonidine in supraclavicular brachial plexus block. Indian J Pain 2015;29:41-5.

Sebastian B, Talikoti AT, Krishnamurthy D. Attenuation of haemodynamic responses to laryngoscopy and endotracheal intubation with intravenous dexmedetomidine: A comparison between two doses. Indian J Anaesth 2017;61:48-54.

Karthik GS, Sudheer R, Sahajananda H, Rangalakshmi S, Kumar R. Dexmedetomidine and clonidine as adjuvants to levobupivacaine in supraclavicular brachial plexus block: A comparative randomised prospective controlled study. J Evol Med Dent Sci 2015;4:3207-22.

Published

07-02-2022

How to Cite

NATARAJAN, N., G. KUPPUSAMY, A. RAMANATHAN, and S. DAVE. “A COMPARATIVE STUDY OF DEXMEDETOMIDINE AND CLONIDINE AS AN ADJUVANT TO ROPIVACAINE IN SUPRACLAVICULAR BRACHIAL PLEXUS BLOCK”. Asian Journal of Pharmaceutical and Clinical Research, vol. 15, no. 2, Feb. 2022, pp. 119-22, doi:10.22159/ajpcr.2022.v15i2.43752.

Issue

Section

Original Article(s)